Innospec Q2 net income falls to $23.5 million; revenue up 1% to $439.7 million
Innospec reported results for the quarter ended June 30, 2025, in a press release furnished under Item 2.02. Revenue rose 1% but net income fell to $23.5 million, or 94 cents per diluted share, from $31.2 million, or $1.24, a year earlier, with the company citing lower results in Performance Chemicals and Oilfield Services.
Key points
- Total revenue was $439.7 million, up 1% from $435.0 million a year earlier.
- Net income was $23.5 million, or 94 cents per diluted share, versus $31.2 million, or $1.24, in the prior-year quarter.
- Adjusted non-GAAP EPS was $1.26 versus $1.39 a year earlier; Performance Chemicals operating income fell 33% to $14.3 million.
- The company reported net cash of $266.6 million with no debt and $8.2 million in share repurchases during the quarter.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.